BMC MUSCULOSKELETAL DISORDERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2024-05-25 Win Victory 来自浙江省

投稿命中率:50.0
偏重的研究方向：骨科 MR分析
经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下

Submission under peer review
15 Apr 2024
Technical check
Submission status Date
Submission passed technical check
15 Apr 2024
Amendment received
14 Apr 2024
Submission is under technical check
12 Apr 2024
Submission received
Submission status Date
Submission received
12 Apr 2024

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2024-07-29 ms2000002008843481 来自广东省

审稿速度:6.0
经验分享：是够慢的，虽然还是接收了，来来回回六七个月

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2024-05-29 骨科小秃头来自江苏省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：骨科
经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧
Peer review
Submission status Date
Submission under peer review
08 Mar 2024
Technical check
Submission status Date
Submission passed technical check
08 Mar 2024
Amendment received
08 Mar 2024
Submission is under technical check
07 Mar 2024
Submission received
07 Mar 2024

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2022-11-09 ms3000000919382660

偏重的研究方向：骨科;骨性关节炎
经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭

192 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2024-01-25 ayouvs 来自贵州省

前面平均间隔一月一修，大修，小修，编辑修
然后三个月没音讯，催了两次才接收
Publishing and rights
Submission status Date
Publishing and rights complete
20 Jan 2024
Submission is in publishing and rights
17 Jan 2024
Peer review
Submission status Date
Submission accepted
13 Jan 2024
Submission under peer review
27 Sep 2023
Submission passed technical check
27 Sep 2023
Revision received
27 Sep 2023
Submission under peer review
21 Aug 2023
Submission passed technical check
21 Aug 2023
Revision received
20 Aug 2023
Submission under peer review
19 Jul 2023
Submission passed technical check
19 Jul 2023
Amendment received
19 Jul 2023
Amendment received
18 Jul 2023
Revision received
14 Jul 2023
Submission under peer review
07 Jun 2023
Technical check
Submission status Date
Submission passed technical check
07 Jun 2023
Amendment received
06 Jun 2023
Amendment received
06 Jun 2023
Amendment received
04 Jun 2023
Submission is under technical check
02 Jun 2023
Submission received
Submission status Date
Submission received
02 Jun 2023

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2023-12-03 ms2000001312611838 来自山西省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脊柱;骨科
经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投

79 0

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2023-11-02 Adamt 来自陕西省

审稿速度:2.0 | 投稿命中率:95.0
经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验
Submission is in publishing and rights
30 Oct 2023
Submission accepted
30 Oct 2023
Submission under peer review
13 Oct 2023
Submission passed technical check
13 Oct 2023
Amendment received
13 Oct 2023
Revision received
11 Oct 2023
Submission under peer review
14 Sep 2023
Technical check
Submission status Date
Submission passed technical check
14 Sep 2023
Amendment received
14 Sep 2023
Submission is under technical check
23 Aug 2023
Submission received

106 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2023-09-11 万里无云来自河北省

这个杂志技术审查那么久啊，一个月了，还没审查结束

125 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2023-05-11 ala 来自陕西省

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：骨科
经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。

Submission rejected 03May2023
Submission under peer review 07Apr2023
Submission passed technical check 07Apr2023
Revision received 07Apr2023
Submission under peer review 02 Nov 2022
Submission passed technical check 02Nov2022
Amendment received 02Nov2022
Submission is under technical check 270ct 2022
Submission received 270ct 2022

174 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207326, encodeId=c4eb220e326c5, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：骨科 经验分享：5月份的时候催了一下，说是没找到审稿人，这也太慢了吧 Peer review Submission status Date Submission under peer review 08 Mar 2024 Technical check Submission status Date Submission passed technical check 08 Mar 2024 Amendment received 08 Mar 2024 Submission is under technical check 07 Mar 2024 Submission received 07 Mar 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27868484560, createdName=骨科小秃头, createdTime=Wed May 29 23:24:40 CST 2024, time=2024-05-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183843, encodeId=262221838433e, content=前面平均间隔一月一修，大修，小修，编辑修 然后三个月没音讯，催了两次才接收 Publishing and rights Submission status Date Publishing and rights complete 20 Jan 2024 Submission is in publishing and rights 17 Jan 2024 Peer review Submission status Date Submission accepted 13 Jan 2024 Submission under peer review 27 Sep 2023 Submission passed technical check 27 Sep 2023 Revision received 27 Sep 2023 Submission under peer review 21 Aug 2023 Submission passed technical check 21 Aug 2023 Revision received 20 Aug 2023 Submission under peer review 19 Jul 2023 Submission passed technical check 19 Jul 2023 Amendment received 19 Jul 2023 Amendment received 18 Jul 2023 Revision received 14 Jul 2023 Submission under peer review 07 Jun 2023 Technical check Submission status Date Submission passed technical check 07 Jun 2023 Amendment received 06 Jun 2023 Amendment received 06 Jun 2023 Amendment received 04 Jun 2023 Submission is under technical check 02 Jun 2023 Submission received Submission status Date Submission received 02 Jun 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bksib3XwnJ2dTyOoRlAuicfPIh74pfjweLQSaNM5hAZvicKicy1E8H84TP0Qm5VS6ABKZVOWibuWo4wXTMOnZM5o8bw/132, createdBy=882d5261151, createdName=ayouvs, createdTime=Thu Jan 25 10:58:39 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省)]

2023-10-12 ms4000001388192116 来自江苏省

上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。

104 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务